← Back to directory

Pascale Tomasini

Researcher Next ID · RN-042867

Researcher · Biochemistry, Genetics and Molecular Biology

Centre National de la Recherche Scientifique

Paris, New Zealand

Accepting doctoral researchersFunding unknown
Works count
326
Citation count
4,751
H-index
33
i10-index
68

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Lung Cancer Treatments and Mutations
Lung Cancer Research Studies
Cancer Genomics and Diagnostics
Cancer Immunotherapy and Biomarkers
Lung Cancer Diagnosis and Treatment

Publications

  • Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

    Annals of Oncology · 2023 · https://doi.org/10.1016/j.annonc.2023.10.117

  • Selpercatinib in Patients With RET Fusion–Positive Non–Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial

    Journal of Clinical Oncology · 2022 · https://doi.org/10.1200/jco.22.00393

  • Prognostic and predictive effects of TP53 co-mutation in patients with EGFR -mutated non-small cell lung cancer (NSCLC)

    Lung Cancer · 2017 · https://doi.org/10.1016/j.lungcan.2017.06.014

Current projects

    No projects listed.